| Variables . | No. (%) . | Variables . | No. (%) . |
|---|---|---|---|
| Age (median, range) | 62 (17–86) years | Procedures | |
| Sex | Lobectomy | 1212 (81.5%) | |
| Male | 1042 (70.1%) | Bilobectomy | 106 (7.1%) |
| Female | 445 (29.9%) | Pneumonectomy | 169 (11.4%) |
| Histology | Pathological T status | ||
| ADC | 856 (57.6%) | Tis/T1a | 224 (15.1%) |
| ADSqCC | 615 (41.3%) | T1b | 263 (17.7%) |
| SqCC | 16 (1.1%) | T2a | 608 (40.9%) |
| Lobe | T2b | 156 (10.5%) | |
| Right upper | 436 (29.3%) | T3 | 193 (13.0%) |
| Right middle | 117 (7.9%) | T4 | 43 (2.9%) |
| Right lower | 352 (23.7%) | No. of resected lymph nodes | |
| Left upper | 323 (21.7%) | Median | 26 |
| Left lower | 259 (17.4%) | Range | 6–75 |
| Variables . | No. (%) . | Variables . | No. (%) . |
|---|---|---|---|
| Age (median, range) | 62 (17–86) years | Procedures | |
| Sex | Lobectomy | 1212 (81.5%) | |
| Male | 1042 (70.1%) | Bilobectomy | 106 (7.1%) |
| Female | 445 (29.9%) | Pneumonectomy | 169 (11.4%) |
| Histology | Pathological T status | ||
| ADC | 856 (57.6%) | Tis/T1a | 224 (15.1%) |
| ADSqCC | 615 (41.3%) | T1b | 263 (17.7%) |
| SqCC | 16 (1.1%) | T2a | 608 (40.9%) |
| Lobe | T2b | 156 (10.5%) | |
| Right upper | 436 (29.3%) | T3 | 193 (13.0%) |
| Right middle | 117 (7.9%) | T4 | 43 (2.9%) |
| Right lower | 352 (23.7%) | No. of resected lymph nodes | |
| Left upper | 323 (21.7%) | Median | 26 |
| Left lower | 259 (17.4%) | Range | 6–75 |
ADC: adenocarcinoma; SqCC: squamous cell carcinoma, ADSqCC: adenosquamous carcinoma.
| Variables . | No. (%) . | Variables . | No. (%) . |
|---|---|---|---|
| Age (median, range) | 62 (17–86) years | Procedures | |
| Sex | Lobectomy | 1212 (81.5%) | |
| Male | 1042 (70.1%) | Bilobectomy | 106 (7.1%) |
| Female | 445 (29.9%) | Pneumonectomy | 169 (11.4%) |
| Histology | Pathological T status | ||
| ADC | 856 (57.6%) | Tis/T1a | 224 (15.1%) |
| ADSqCC | 615 (41.3%) | T1b | 263 (17.7%) |
| SqCC | 16 (1.1%) | T2a | 608 (40.9%) |
| Lobe | T2b | 156 (10.5%) | |
| Right upper | 436 (29.3%) | T3 | 193 (13.0%) |
| Right middle | 117 (7.9%) | T4 | 43 (2.9%) |
| Right lower | 352 (23.7%) | No. of resected lymph nodes | |
| Left upper | 323 (21.7%) | Median | 26 |
| Left lower | 259 (17.4%) | Range | 6–75 |
| Variables . | No. (%) . | Variables . | No. (%) . |
|---|---|---|---|
| Age (median, range) | 62 (17–86) years | Procedures | |
| Sex | Lobectomy | 1212 (81.5%) | |
| Male | 1042 (70.1%) | Bilobectomy | 106 (7.1%) |
| Female | 445 (29.9%) | Pneumonectomy | 169 (11.4%) |
| Histology | Pathological T status | ||
| ADC | 856 (57.6%) | Tis/T1a | 224 (15.1%) |
| ADSqCC | 615 (41.3%) | T1b | 263 (17.7%) |
| SqCC | 16 (1.1%) | T2a | 608 (40.9%) |
| Lobe | T2b | 156 (10.5%) | |
| Right upper | 436 (29.3%) | T3 | 193 (13.0%) |
| Right middle | 117 (7.9%) | T4 | 43 (2.9%) |
| Right lower | 352 (23.7%) | No. of resected lymph nodes | |
| Left upper | 323 (21.7%) | Median | 26 |
| Left lower | 259 (17.4%) | Range | 6–75 |
ADC: adenocarcinoma; SqCC: squamous cell carcinoma, ADSqCC: adenosquamous carcinoma.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
